FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Cytokinetics Reports Exercise Data on Heart Drug

[ Price : $8.95]

Cytokinetics reports topline results from its Phase 3 MAPLE-HCM clinical trial showing that aficamten significantly improved exerc...

Hunter Syndrome Gene Therapy Accepted for Review

[ Price : $8.95]

FDA accepts for priority review a Regenxbio BLA seeking accelerated approval for gene therapy RGX-121 (clemidsogene lanparvovec) f...

Taizhou Jingshang Cosmetics CGMP Issues

[ Price : $8.95]

FDA warns Chinas Taizhou Jingshang Cosmetics Technology Co. about CGMP violations in its production of finished drugs.

FDA Hits Mayne Nextstellis Professional Presentation

[ Price : $8.95]

The CDER Office of Prescription Drug Promotion hits Mayne Pharma over a professional presentation on Nextstellis that it says make...

GSK, iTeos Therapeutics Scrap Lung Cancer Candidate

[ Price : $8.95]

GSK and iTeos Therapeutics decide to stop the development of belrestotug, an anti-TIGIT monoclonal antibody for treating certain n...

FDA Needs GLP-1 Long-Range Plan: Kessler

[ Price : $8.95]

Former FDA commissioner David Kessler, who is taking one of the new weight loss drugs, calls on FDA to require data to help people...

Capillary Bio Wearable Infusion Set Cleared

[ Price : $8.95]

FDA clears a Capillary Biomedical 510(k) for its SteadiSet, a wearable infusion set that delivers insulin from a pump to the body ...

GEs Optison OKd for Pediatric Heart Imaging

[ Price : $8.95]

FDA approves GE HealthCares ultrasound imaging agent Optison 9 for use in pediatric patients.

Indian API Maker Hit with Warning Letter

[ Price : $8.95]

FDA sends Indian active pharmaceutical ingredient manufacturer Mentha & Allied Products a Warning Letter that cites the firm for s...

FDA Wants Public Deregulation Input

[ Price : $8.95]

FDA and HHS ask public stakeholders for their ideas on regulations that should be eliminated.